Literature DB >> 30030845

Alveolar bone resorption and Th1/Th17-associated immune response triggered during Aggregatibacter actinomycetemcomitans-induced experimental periodontitis are serotype-dependent.

Gustavo Monasterio1, Francisca Castillo1, Juan Pablo Ibarra1, José Guevara1, Leticia Rojas1, Carla Alvarez1, Baltasar Fernández1, Amaru Agüero1, Daniel Betancur2, Rolando Vernal1,3.   

Abstract

BACKGROUND: Aggregatibacter actinomycetemcomitans expresses several virulence factors that may contribute to the pathogenesis of periodontitis. Based on the antigenicity of the O-polysaccharide component of the lipopolysaccharide (LPS), different A. actinomycetemcomitans serotypes have been described. Among them, serotype b has demonstrated a stronger capacity to trigger Th1 and Th17-associated cytokine, CC-chemokine, and CC-chemokine receptor production on immune cells in vitro. With a murine model of experimental periodontitis, this investigation aimed to analyze the alveolar bone resorption and the pattern of immune response triggered by the different A. actinomycetemcomitans serotypes within periodontal lesions.
METHODS: For periodontal lesion induction, mice were orally infected with the different A. actinomycetemcomitans serotypes or their purified LPS. Alveolar bone resorption was analyzed using microcomputed tomography and scanning electron microscopy. Bacterial infection, receptor activator of nuclear factor-kappa B ligand (RANKL) and Th1 and Th17-associated cytokine, CC-chemokine, and CC-chemokine receptor levels were quantified by quantitative polymerase chain reaction (qPCR). T lymphocytes isolated from periodontal lesions were analyzed by flow cytometry.
RESULTS: In periodontal lesions, serotype b of A. actinomycetemcomitans induced higher alveolar bone resorption and expression of RANKL compared with the other serotypes. In addition, serotype b induced greater levels of Th1- and Th17-related cytokines, CC-chemokines, and CC-chemokine receptors than the others. Similarly, higher numbers of infiltrating Th1 and Th17 lymphocytes were detected in serotype b-induced periodontal lesions.
CONCLUSIONS: These results demonstrate that periodontal lesions induced with different A. actinomycetemcomitans serotypes elicited distinct alveolar bone resorption and immune response. In particular, serotype b was more pathogenic than the others and induced stronger Th1 and Th17 patterns of immune responses during experimental periodontitis.
© 2018 American Academy of Periodontology.

Entities:  

Keywords:  Aggregatibacter actinomycetemcomitans; RANKL; T lymphocytes; bone resorption; chemokine receptors; chemokines; cytokines

Mesh:

Year:  2018        PMID: 30030845     DOI: 10.1002/JPER.17-0563

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  16 in total

1.  Levels of low-molecular-weight hyaluronan in periodontitis-treated patients and its immunostimulatory effects on CD4+ T lymphocytes.

Authors:  Francisca Castillo; Gustavo Monasterio; Juan Pablo Ibarra; José Guevara; Emilio A Cafferata; Emiliano Vicencio; Cristian Cortez; Paola Carvajal; Rolando Vernal
Journal:  Clin Oral Investig       Date:  2021-02-05       Impact factor: 3.573

Review 2.  Polarization Profiles of T Lymphocytes and Macrophages Responses in Periodontitis.

Authors:  Franco Cavalla; Marcela Hernández
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

3.  Calcitriol inhibits osteoclastogenesis in an inflammatory environment by changing the proportion and function of T helper cell subsets (Th2/Th17).

Authors:  Chun-Sheng Bi; Xuan Li; Hong-Lei Qu; Li-Juan Sun; Ying An; Yong-Long Hong; Bei-Min Tian; Fa-Ming Chen
Journal:  Cell Prolif       Date:  2020-05-13       Impact factor: 6.831

Review 4.  The role of dendritic cells derived osteoclasts in bone destruction diseases.

Authors:  Bo Wang; Yutong Dong; Zhansong Tian; Yueqi Chen; Shiwu Dong
Journal:  Genes Dis       Date:  2020-04-07

Review 5.  Humanized Mouse Models for the Study of Periodontitis: An Opportunity to Elucidate Unresolved Aspects of Its Immunopathogenesis and Analyze New Immunotherapeutic Strategies.

Authors:  Carolina Rojas; Michelle P García; Alan F Polanco; Luis González-Osuna; Alfredo Sierra-Cristancho; Samanta Melgar-Rodríguez; Emilio A Cafferata; Rolando Vernal
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561

Review 6.  Osteoimmunology: A Current Update of the Interplay Between Bone and the Immune System.

Authors:  Christian Guder; Sascha Gravius; Christof Burger; Dieter C Wirtz; Frank A Schildberg
Journal:  Front Immunol       Date:  2020-01-31       Impact factor: 7.561

7.  Alzheimer's Disease-Like Pathology Triggered by Porphyromonas gingivalis in Wild Type Rats Is Serotype Dependent.

Authors:  Jaime Díaz-Zúñiga; Jamileth More; Samanta Melgar-Rodríguez; Matías Jiménez-Unión; Francisca Villalobos-Orchard; Constanza Muñoz-Manríquez; Gustavo Monasterio; José Luis Valdés; Rolando Vernal; Andrea Paula-Lima
Journal:  Front Immunol       Date:  2020-11-09       Impact factor: 7.561

8.  O-Polysaccharide Plays a Major Role on the Virulence and Immunostimulatory Potential of Aggregatibacter actinomycetemcomitans During Periodontal Infection.

Authors:  Gustavo Monasterio; Francisca Castillo; Jessica Astorga; Anilei Hoare; Claudia Terraza-Aguirre; Emilio A Cafferata; Eduardo J Villablanca; Rolando Vernal
Journal:  Front Immunol       Date:  2020-10-30       Impact factor: 7.561

9.  Regulatory T cell phenotype and anti-osteoclastogenic function in experimental periodontitis.

Authors:  Carla Alvarez; Salwa Suliman; Rawan Almarhoumi; Maria Elena Vega; Carolina Rojas; Gustavo Monasterio; Mario Galindo; Rolando Vernal; Alpdogan Kantarci
Journal:  Sci Rep       Date:  2020-11-04       Impact factor: 4.379

10.  The relationship between T-helper cell polarization and the RANKL/OPG ratio in gingival tissues from chronic periodontitis patients.

Authors:  Chun-Sheng Bi; Li-Juan Sun; Hong-Lei Qu; Fang Chen; Bei-Min Tian; Fa-Ming Chen
Journal:  Clin Exp Dent Res       Date:  2019-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.